• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO PROVUE; AUTOMATED BLOOD GROUPING & ANTIBODY TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO PROVUE; AUTOMATED BLOOD GROUPING & ANTIBODY TEST SYSTEM Back to Search Results
Catalog Number MTS213784
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/21/2018
Event Type  malfunction  
Manufacturer Narrative
Tsc discussed with customer different processes when comparing gel manual method to provue analyzer.Tsc also discussed with customer when loading 0.8% resolve panel a lot# vra296 onto provue that cell #3 may have possibly not been mixed properly limiting the e antigen sites to be exposed to anti-e in patient plasma sample.Tsc also discussed with customer titer of anti-e in patient plasma sample in question.Customer does not request service at this time as only one patient affected and does not request replacement product as qc not affected.The root-cause could not be confirmed although the most probable root cause is associated with an anti-e antibody being weak and/or at the detection limit of the technique and reagents used.No incorrect or erroneous results were reported as a result of this incident.There was no risk present at the time of the incident.There was no harm to any patient.A complaint review was performed dra# (b)(4).Only this event was reported for the provue in question.
 
Event Description
Customer contacted tsc to report upon performing antibody identification on a single patient sample with 0.8% resolve panel a lot# vra296, exp: 3.27.2018 tested on mts igg gel cards lot#081417001-03, exp: may 5 2018, failed to react with e homozygous donor (cell#3) from panel on provue analyzer.Customer tested 0.8% resolve panel a lot# vra296 in question with patient sample in manual gel method and patient got a 1+ pos reaction with donor/vial#3 (15 min incubation period).Customer reports no harm to patient due to this event and patient not transfused and this is new antibody identified.Customer initially tested patient in question with 0.8% selectogen lot# vs097, exp 3.27.2018 and patient reacted with cell#2, with a 2+ pos reaction on provue analyzer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORTHO PROVUE
Type of Device
AUTOMATED BLOOD GROUPING & ANTIBODY TEST SYSTEM
Manufacturer Contact
matthew p wictome
1001 route 202
raritan, NJ 08869
9082188223
MDR Report Key7436015
MDR Text Key106712855
Report Number1056600-2018-00057
Device Sequence Number1
Product Code KSZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Medical Technologist
Type of Report Initial
Report Date 04/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMTS213784
Device Lot Number3.1.1
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/21/2018
Initial Date FDA Received04/17/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/09/2008
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-